I stedet kan firmaerne fremstille en vaccine med en influenzavirusstamme, der specifikt udvælges, fordi ingen personer har været udsat for smitte med den, og ingen er immune over for den.
Instead, they can prepare a vaccine that contains a strain of flu virus specifically chosen because nobody has been exposed to it, and to which nobody is immune.